Human Investing’s Bausch Health BHC Stock Holding History

Human Investing’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-827	Closed	-$15K	–	306
2020 Q2	$15K	Hold	827	–	–	0.01%	203
2020 Q1	$13K	Hold	827	–	–	0.01%	211
2019 Q4	$25K	Hold	827	–	–	0.01%	235
2019 Q3	$18K	Hold	827	–	–	0.01%	246
2019 Q2	$21K	Hold	827	–	–	0.01%	243
2019 Q1	$20K	Hold	827	–	–	0.01%	227
2018 Q4	$15K	Buy	+827	New	+$19.7K	0.01%	253

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Human Investing's BHC Position: Q3 2020 in Review

Human Investing sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 827 shares — an estimated $15K sold.

Human Investing first reported a position in BHC in Q4 2018 and held it in 7 quarters. The position peaked at $25K in Q4 2019. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Human Investing reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Human Investing sold 827 Bausch Health shares in Q3 2020, an estimated $15K.
Human Investing first reported a position in Bausch Health in Q4 2018 and held it in 7 quarters.
Human Investing's Bausch Health position peaked at $25K in Q4 2019.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Human Investing's 13F filing for Q3 2020, filed 27 Oct 2020.